View Clinical Trial (Medical Research Study)
Minimally Invasive Surgery: Using Natural Orfices - NCT00530998-92103(Clinical Trial 185233)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
San Diego |
|
State:
|
|
CA |
| Zip Code: |
|
92103 |
| Conditions: |
|
Appendicitis - Cholelithiasis - Gallstones |
| Purpose: |
|
A research study to find out more about an investigational approach to perform surgery that
has not been done in humans before at this institution. Normally this type of surgery would
be done laparoscopically or open. Laparoscopic surgery is where the doctor would make
several (3-6) small opening in the abdomen; places a camera and other instruments and
removes the gallbladder through a small incision in the lower right abdomen. Open surgery
is where the doctor makes approximately a 6 inch incision into the abdomen and removes the
gallbladder. This investigational procedure is called Natural Orifice Translumenal
Endoscopic Surgery (NOTES). This means that surgery would be done through the mouth, vagina
or rectum. In this study, the doctor will perform this investigational method of surgery
through the vagina.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Group #1 NOTES Appendectomy - Transvaginal approach:
Inclusion criteria for transvaginal appendectomy:
1. Females between the ages of 18-50
2. Clinical diagnosis of appendicitis
3. Emergency room evaluation within 48 hours of the onset of pain
4. ASA Classification 1
Exclusion criteria for transvaginal appendectomy:
1. Pregnant women (need to have negative icon in ER)
2. Morbidly obese patients (BMI >35)
3. Patients who are taking immunosuppressive medications or are immunocompromised
4. Patients with evidence of an abdominal abscess or mass
5. Patients who present with a clinical diagnosis of sepsis or peritonitis
6. Patients who have a history of prior open abdominal surgery or prior transvaginal
surgery. Patients with prior laparoscopic surgery will be included.
7. Patients who endorse a history of ectopic pregnancy, pelvic inflammatory disease
(PID), or severe endometriosis
8. Patients with diffuse peritonitis on clinical exam
9. Previous trauma to the perineal area
10. Patients on blood thinners or aspirin or abnormal blood coagulation tests.
Group #2 NOTES Cholecystectomy - Transvaginal approach:
Inclusion criteria for transvaginal cholecystectomy:
1. Females between the ages of 18 and 50
2. Diagnosis of gallstone disease which requires cholecystectomy
3. ASA class 1
Exclusion criteria for transvaginal cholecystectomy:
1. Pregnant women
2. Morbidly obese patients (BMI > 35)
3. Patients who are taking immunosuppressive medications and/or immunocompromised
4. Patients with severe medical comorbidities will be excluded.
5. Patients with a presumed gallbladder polyps, mass or tumor
6. Patients with a history of prior open abdominal or transvaginal surgery. Patients
with prior laparoscopic surgery will be included.
7. Patients with a prior history of peritoneal or vaginal trauma
8. Patients with a history of ectopic pregnancy, pelvic inflammatory disease, or severe
endometriosis
9. Patients with known common bile duct stones
10. Patients on blood thinners or aspirin or abnormal blood coagulation tests |
|
|
|
| Study is available at: |
|
University of California, San Diego San Diego, CA 92103 United States
Primary Contact: Julie A Bosia, BSN Email: misresearch@ucsd.edu Phone: 619-471-0447 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|